Story perspectives

Oxford Trial: Pramipexole Shows Promise for Depression Treatment

7/14/2025

37 3

Summary

Story summary

A University of Oxford trial demonstrated pramipexole's effectiveness for treatment-resistant depression, surpassing placebo results in 150 patients over 48 weeks.
Significant symptom reduction occurred by week 12, though 20% of participants discontinued due to side effects like nausea and dizziness.
This study positions pramipexole as a promising alternative to traditional antidepressants.
Additional research is essential to evaluate side effects and cost-effectiveness.

1 of 1

Story summary

A University of Oxford trial demonstrated pramipexole's effectiveness for treatment-resistant depression, surpassing placebo results in 150 patients over 48 weeks.
Significant symptom reduction occurred by week 12, though 20% of participants discontinued due to side effects like nausea and dizziness.
This study positions pramipexole as a promising alternative to traditional antidepressants.
Additional research is essential to evaluate side effects and cost-effectiveness.